These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3218454)

  • 1. Operative treatment of recurrent cancer of the uterine cervix after radiotherapy.
    Ibsen TB; Sørensen BL; Knudsen JB; Sørensen HM
    Acta Obstet Gynecol Scand; 1988; 67(5):389-93. PubMed ID: 3218454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
    Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
    Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
    Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
    Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical therapy in recurrences and the therapeutic sequelae].
    Käser O; Castaño y Almendral A
    Strahlenther Onkol; 1986 Nov; 162(11):671-4. PubMed ID: 3787452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.
    Spahn M; Weiss C; Bader P; Frohneberg D; Studer UE; Burkhard FC
    Urol Int; 2010; 85(1):16-22. PubMed ID: 20299775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of recurrent cervical cancer.
    Selman AE; Copeland LJ
    Yonsei Med J; 2002 Dec; 43(6):754-62. PubMed ID: 12497659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of loco-regional recurrences of cervix cancers].
    Bobin JY; Romestaing P; Gérard JP
    Ann Chir; 1999; 53(9):904. PubMed ID: 10633941
    [No Abstract]   [Full Text] [Related]  

  • 10. Major morbidity after pelvic exenteration: a seven-year experience.
    Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
    Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy.
    Höckel M; Horn LC; Einenkel J
    Gynecol Oncol; 2012 Nov; 127(2):297-302. PubMed ID: 22864112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical hysterectomy in the treatment of cervical cancer.
    Benedet JL; Turko M; Boyes DA; Nickerson KG; Bienkowska BT
    Am J Obstet Gynecol; 1980 May; 137(2):254-62. PubMed ID: 7377245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection.
    Krebs HB; Helmkamp BF; Sevin BU; Poliakoff SR; Nadji M; Averette HE
    Obstet Gynecol; 1982 Apr; 59(4):422-7. PubMed ID: 7078892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic-assisted laparoscopic exenteration in recurrent cervical cancer Robotics improved the surgical experience for 2 women with recurrent cervical cancer.
    Davis MA; Adams S; Eun D; Lee D; Randall TC
    Am J Obstet Gynecol; 2010 Jun; 202(6):663.e1. PubMed ID: 20510970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.
    Coleman RL; Keeney ED; Freedman RS; Burke TW; Eifel PJ; Rutledge FN
    Gynecol Oncol; 1994 Oct; 55(1):29-35. PubMed ID: 7959262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenterative therapy and the treatment of recurrent carcinoma of the cervix.
    Morley GW
    Semin Oncol; 1982 Sep; 9(3):331-40. PubMed ID: 7134995
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].
    Chen M; Pan L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):460-5. PubMed ID: 25169641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent cervical cancer.
    Leitao MM; Chi DS
    Curr Treat Options Oncol; 2002 Apr; 3(2):105-11. PubMed ID: 12057073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
    Manzour N; Vázquez-Vicente D; Carriles I; Boria F; Chacon E; Chiva L
    Int J Gynecol Cancer; 2021 Aug; 31(8):1188-1189. PubMed ID: 34031133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.